Drug Trial Radar · NCT06257537
Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis
Last checked: Nov 20, 2026Latest source record: Jun 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
307
Actual
Start
Oct 1, 2024
Primary completion
Jun 26, 2026
Study completion Jun 26, 2026
Sponsor
- Lead sponsor
- ZetrOZ, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 14, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years, up to 85 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the ability of long-duration low intensity therapeutic ultrasound (LITUS) to alleviate knee Osteoarthritis pain over a 24-week period. The primary objective of this study is to evaluate the analgesic effect of LITUS in subjects suffering from knee Osteoarthritis pain. Secondary objectives are to assess the ability of LITUS to improve joint function.
Conditions
- Osteo Arthritis Knee
- Arthritis
Interventions
Sustained Acoustic Device with 2.5% Diclofenac PatchDevice
Patients apply the SAM Ultrasonic Diathermy Device daily for 1-4 hours of continuous therapeutic ultrasound at 3 megahertz(MHz) frequency and 0.132 Watts/cm\^2 with 2.5% Diclofenac patches.
Sustained Acoustic Device with 0% Diclofenac PatchDevice
Patients apply the SAM Ultrasonic Diathermy Device daily for 1-4 hours with 0% diclofenac patches.
2.5% Diclofenac PatchesDrug
Topical pain relief-gel worn for 4 hours at least 5 days a week via SAM patch.
SAM PatchOther
Ultrasound gel without additional pain relief medication worn for 4 hours at least 5 days a week via SAM patch.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Pain Units on a Scale (0-10) 0 Being Least, 10 Being Worst Pain From BaselineTime frame: Through study completion, average of 24 weeks.
- Change in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)Time frame: Through study completion, average of 24 weeks.
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Orthopaedic Foundation
Stamford, Connecticut
ZetrOZ Systems
Trumbull, Connecticut
Cayuga Medical Center - Medical Pain Consultants
Dryden, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.